PRKAA1 and steatosis: The results suggested that fucoidan inhibited alcohol-induced steatosis, inflammation and oxidative stress through the AMPK/SIRT1 signaling pathway, and improved the disorder of bile acid metabolism by regulating gut microbiota-bile acid-liver axis.